Clinical Trial Update: The Addition of Montelukast to Fluticasone in the Treatment of Perennial Allergic Rhinitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the addition of montelukast to intranasal fluticasone for perennial allergic rhinitis was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis Perennial

Drugs mentioned

• Fluticasone (fluticasone propionate)
• Montelukast (Montelukast)

Snippet

Sponsor: University of Chicago | Conditions: Rhinitis, Allergic, Perennial | Phase 4 | Status: TERMINATED | Results posted: 2013-05-22